CV Lattes
ORCID
Google Scholar Citations
Universidade de São Paulo (USP). Instituto de Ciências Biomédicas (ICB) (Institutional affiliation for the last research proposal) Birthplace: Brazil
graduation at CIências Biológicas from Universidade do Estado da Bahia (2008), master's at Imunologia from Universidade Federal da Bahia (2011) and doctorate at Immunology from Universidade de São Paulo (2014). Has experience in Immunology, focusing on Immunology (Source: Lattes Curriculum)
| Articles published in Pesquisa FAPESP Magazine about the researcher: |
| Standing alone |
| The puzzle of immunity |
| Para caminar por sus propios medios |
| El rompecabezas de la inmunidad |
| Articles published in Pesquisa para Inovação FAPESP about the researcher: |
| FAPESP-funded startups are developing COVID-19 vaccines |
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The emerging SARS-CoV-2 virus appeared in China and easily spread around the world with a tremendous lethality. In less than three months of its identification, it has already caused more than 30,000 deaths worldwide with an increasing number of fatalities. As it is a new virus introduced into the human population, therefore there is no prior immunity; it has easy spread and lethality var…
Neglected tropical diseases typically affect low- to middle income patients; drug and vaccine development by vaccine industries is impaired due to the lack of prospects for financial gain. Streptococcus pyogenes, also termed Group A Streptococcus (GAS), is a human restricted pathogen responsible for a large variety of diseases, such as Acute Rheumatic Fever (ARF) and Rheumatic Heart Disea…
At the end of December 2019, the WHO (World Health Organization) was alerted about several cases of pneumonia in the city of Wuhan, China, caused by a new coronavirus that had never been identified in humans. Approximately one month later, on January 30, 2020, the WHO declared the outbreak of novel coronavirus infection as a public health emergency and on March 11, 2020, Covid-19 (disease…
SARS-CoV-2 vaccines must be one step ahead of the rapid evolution of the virus. Therefore immunogenic and flexible vaccine platforms are needed. Variants of concern (VOCs) that continually emerge with an unprecedented spread of the virus have already significantly increased the transmissibility and severity of COVID-19 and affected the efficacy and effectiveness of vaccines and vaccinatio…
The Zika Virus (ZIKV) is a flavivirus transmitted by the bite of arthropods of the genus Aedes, but also through blood transfusion, through sexual or maternal-fetal routes. Since its discovery in 1947, its infection was previously restricted to mild and subclinical cases, however, a major outbreak that began in 2015 in Brazil, has called the attention of public health authorities, since t…
(Only some records are available in English at this moment)
The emerging SARS-CoV-2 virus appeared in China and easily spread around the world with a tremendous lethality. In less than three months of its identification, it has already caused more than 30,000 deaths worldwide with an increasing number of fatalities. As it is a new virus introduced into the human population, therefore there is no prior immunity; it has easy spread and lethality var…
| 2 / 2 | Ongoing research grants |
| 5 / 5 | Ongoing scholarships in Brazil |
| 1 / 1 | Completed scholarships in Brazil |
| 8 / 8 | All research grants and scholarships |
| Associated processes | |